UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-08-02 | -0.94 | -0.94 |
| Q1 2022 | 2022-04-26 | -1.04 | -1.04 |
| Q4 2021 | 2022-02-22 | -1.28 | -1.28 |
| Q3 2021 | 2021-11-02 | -0.97 | -0.97 |
| Q2 2021 | 2021-07-28 | -1.03 | -1.03 |
| Q1 2021 | 2021-05-04 | -0.18 | -0.18 |
| Q4 2020 | 2021-02-16 | -2.79 | -2.79 |
| Q3 2020 | 2020-10-27 | -1.46 | -1.46 |
| Q2 2020 | 2020-07-30 | -0.58 | -0.58 |
| 2016-06-22 | Reiterated Rating | Craig Hallum | Buy | |
| 2016-06-22 | Reiterated Rating | Robert W. Baird | Outperform | $12.00 to $15.00 |
| 2016-06-16 | Upgrade | Craig Hallum | Hold to Buy | $6.00 to $18.00 |
| 2016-06-15 | Reiterated Rating | Mizuho | Hold | $6.50 |
| 2016-06-15 | Reiterated Rating | BTIG Research | Buy | $9.00 |
| 2016-06-15 | Reiterated Rating | William Blair | Buy | |
| 2016-06-15 | Reiterated Rating | Roth Capital | Hold | $7.00 to $7.00 |
| 2016-06-15 | Reiterated Rating | Jefferies Group | Buy | $13.00 |
| 2016-06-15 | Reiterated Rating | Canaccord Genuity | Buy | $9.00 to $12.00 |
| 2016-05-24 | Reiterated Rating | BTIG Research | Buy | $9.00 |
| 2016-05-10 | Reiterated Rating | BTIG Research | Buy | |
| 2016-05-04 | Downgrade | Mizuho | Buy to Neutral | $12.00 to $6.50 |
| 2016-05-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-05-02 | Reiterated Rating | Canaccord Genuity | Buy | $9.00 |
| 2016-03-01 | Reiterated Rating | BTIG Research | Buy | $9.00 |
| 2016-02-26 | Lower Price Target | Goldman Sachs | Neutral | $8.00 to $7.00 |
| 2016-02-26 | Lower Price Target | Goldman Sachs Group Inc. | Neutral | $8.00 to $7.00 |
| 2016-02-25 | Lower Price Target | Canaccord Genuity | Buy | $13.00 to $9.00 |
| 2016-02-25 | Downgrade | Stephens | Overweight to Equal Weight | |
| 2016-02-25 | Lower Price Target | Jefferies Group | Buy | $15.00 to $13.00 |
| 2016-02-25 | Downgrade | Roth Capital | Buy to Neutral | |
| 2016-02-24 | Reiterated Rating | Benchmark Co. | Hold | $11.00 to $9.00 |
| 2016-02-24 | Downgrade | Craig Hallum | Buy to Hold | $22.00 to $6.00 |
| 2016-02-19 | Reiterated Rating | Canaccord Genuity | Buy | $13.00 |
| 2016-01-15 | Reiterated Rating | Canaccord Genuity | Buy | $13.00 |
| 2015-12-18 | Initiated Coverage | BTIG Research | Buy | $14.00 |
| 2015-11-24 | Reiterated Rating | Lake Street Capital | Hold | $12.00 to $7.00 |
| 2015-10-30 | Lower Price Target | Roth Capital | Buy | $15.00 to $12.00 |
| 2015-10-30 | Lower Price Target | Wedbush | $7.00 to $6.50 | |
| 2015-10-30 | Lower Price Target | Jefferies Group | $35.00 to $15.00 | |
| 2015-10-30 | Lower Price Target | Goldman Sachs | $11.00 to $10.00 | |
| 2015-10-21 | Upgrade | Stephens | Equal Weight to Overweight | |
| 2015-10-08 | Lower Price Target | Wedbush | Neutral | $18.00 to $7.00 |
| 2015-10-07 | Reiterated Rating | Craig Hallum | Buy | |
| 2015-10-07 | Lower Price Target | Canaccord Genuity | $26.00 to $13.00 | |
| 2015-10-07 | Lower Price Target | Mizuho | Buy | $35.00 to $12.00 |
| 2015-10-06 | Downgrade | Lake Street Capital | Buy to Hold | $30.00 to $16.00 |
| 2015-10-06 | Lower Price Target | Roth Capital | Buy | $31.00 to $15.00 |
| 2015-10-06 | Boost Price Target | Wedbush | Neutral | $7.00 to $18.00 |
| 2015-10-06 | Reiterated Rating | Jefferies Group | Buy | $35.00 |
| 2015-10-06 | Lower Price Target | Goldman Sachs | Neutral | $24.00 to $11.00 |
| 2015-10-06 | Downgrade | Benchmark Co. | Buy to Hold | $34.00 to $11.00 |
| 2015-10-06 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 to $13.00 |
| 2015-10-06 | Reiterated Rating | Stephens | Hold | $25.00 to $14.00 |
| 2015-10-01 | Initiated Coverage | Craig Hallum | Buy | $30.00 |
| 2015-09-09 | Reiterated Rating | Canaccord Genuity | Buy | $26.00 |
| 2015-08-24 | Reiterated Rating | Canaccord Genuity | Buy | $32.00 to $26.00 |
| 2015-07-23 | Upgrade | Lake Street Capital | Hold to Buy | $27.00 to $30.00 |
| 2015-07-21 | Reiterated Rating | Roth Capital | Buy | |
| 2015-07-21 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-07-21 | Reiterated Rating | Mizuho | Buy to Positive | $35.00 |
| 2015-07-21 | Reiterated Rating | Benchmark Co. | Buy | $31.00 to $34.00 |
| 2015-07-13 | Boost Price Target | Roth Capital | Buy | $28.00 to $31.00 |
| 2015-06-29 | Reiterated Rating | Lake Street Capital | Hold | $24.00 to $27.00 |
| 2015-06-28 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-06-27 | Reiterated Rating | William Blair | Outperform | |
| 2015-06-26 | Boost Price Target | Goldman Sachs | Neutral | $23.00 to $26.00 |
| 2015-06-26 | Boost Price Target | Mizuho | Buy | $30.00 to $35.00 |
| 2015-06-22 | Boost Price Target | Canaccord Genuity | Buy | $30.00 to $32.00 |
| 2015-06-20 | Set Price Target | Jefferies Group | Buy | $33.00 |
| 2015-06-04 | Set Price Target | Canaccord Genuity | Buy | $30.00 |
| 2015-05-23 | Reiterated Rating | Jefferies Group | Buy | $33.00 |
| 2015-05-05 | Downgrade | Lake Street Capital | Buy to Hold | $24.00 |
| 2015-05-05 | Boost Price Target | JMP Securities | Outperform | $27.00 to $31.00 |
| 2015-05-05 | Boost Price Target | Roth Capital | Buy | $26.00 to $28.00 |
| 2015-05-04 | Set Price Target | Canaccord Genuity | Buy | $30.00 |
| 2015-03-26 | Downgrade | Goldman Sachs | Buy to Neutral | $29.00 to $24.00 |
| 2015-03-06 | Set Price Target | Roth Capital | Buy | $26.00 |
| 2015-02-25 | Lower Price Target | JMP Securities | Market Outperform | $34.00 to $27.00 |
| 2015-02-25 | Reiterated Rating | Wedbush | Neutral | |
| 2015-02-18 | Set Price Target | Wedbush | Hold | $19.00 |
| 2015-01-23 | Set Price Target | Mizuho | Buy | $26.00 to $30.00 |
| 2015-01-05 | Initiated Coverage | Lake Street Capital | Buy | $33.00 |
| 2014-12-18 | Reiterated Rating | Goldman Sachs | Buy | $25.00 to $32.00 |
| 2014-11-26 | Reiterated Rating | Canaccord Genuity | Buy | $502.00 to $30.00 |
| 2014-10-31 | Reiterated Rating | Canaccord Genuity | Buy | $32.00 to $30.00 |
| 2014-10-28 | Downgrade | Stephens | Overweight to Equal Weight | $23.00 |
| 2014-10-28 | Boost Price Target | Mizuho | Buy | $22.00 to $26.00 |
| 2014-10-13 | Boost Price Target | Maxim Group | Sell | $8.00 to $12.00 |
| 2014-10-13 | Boost Price Target | Benchmark Co. | Buy | $25.00 to $42.00 |
| 2014-10-13 | Reiterated Rating | Wedbush | Neutral | $14.00 to $19.00 |
| 2014-10-10 | Reiterated | ROTH Capital | Buy | $20 to $30 |
| 2014-10-10 | Boost Price Target | Canaccord Genuity | Buy | $23.00 to $32.00 |
| 2014-10-10 | Boost Price Target | Roth Capital | Buy | $20.00 to $30.00 |
| 2014-10-10 | Boost Price Target | Jefferies Group | Buy | $20.00 to $27.00 |
| 2014-10-10 | Boost Price Target | JMP Securities | Outperform | $28.00 to $34.00 |
| 2014-09-03 | Boost Price Target | Goldman Sachs | Buy | $19.00 to $26.00 |
| 2014-08-27 | Boost Price Target | JMP Securities | Market Outperform | $22.00 to $28.00 |
| 2014-08-26 | Boost Price Target | Canaccord Genuity | Buy | $21.00 to $23.00 |
| 2014-08-12 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 to $20.00 |
| 2014-08-12 | Upgrade | Benchmark Co. | Buy | |
| 2014-07-23 | Boost Price Target | Jefferies Group | Buy | $18.00 to $20.00 |
| 2014-07-23 | Reiterated Rating | Maxim Group | In-Line to Sell | |
| 2014-07-23 | Boost Price Target | Canaccord Genuity | Buy | $18.00 to $19.00 |
| 2014-06-04 | Initiated Coverage | Goldman Sachs | Buy | $19.00 |
| 2014-06-04 | Boost Price Target | Canaccord Genuity | $17.00 to $18.00 | |
| 2014-05-30 | Downgrade | Wedbush | Outperform to Neutral | $14.00 |
| 2014-05-02 | Lower Price Target | JMP Securities | Market Outperform | $25.00 to $22.00 |
| 2014-05-01 | Reiterated Rating | Benchmark Co. | Buy | |
| 2014-03-28 | Boost Price Target | Mizuho | $18.00 to $22.00 | |
| 2014-03-28 | Boost Price Target | JMP Securities | Outperform | $17.00 to $25.00 |
| 2014-03-20 | Boost Price Target | Maxim Group | Sell | $6.00 to $8.00 |
| 2014-03-19 | Reiterated Rating | Benchmark Co. | Positive | |
| 2013-10-29 | Reiterated Rating | Maxim Group | Sell | |
| 2013-10-16 | Upgrade | Wedbush | Neutral to Outperform | |
| 2013-09-16 | Initiated Coverage | Summer Street | Buy | |
| 2013-06-07 | Reiterated | Mizuho | Buy | $13 to $18 |
| 2013-04-18 | Reiterated | Maxim Group | Sell | $7 to $6 |
| 2012-10-19 | Reiterated | The Benchmark Company | Speculative Buy | $12 to $17 |
| 2012-07-18 | Initiated | Maxim Group | Sell | $7 |
| 2012-02-24 | Reiterated | Auriga | Buy | $10 to $13 |
| 2011-09-06 | Initiated | Ladenburg Thalmann | Neutral | |
| 2011-06-28 | Initiated | Wedbush | Outperform | $10 |
| 2011-03-01 | Initiated | Auriga U.S.A | Buy | $10 |
| 2010-12-14 | Initiated | William Blair | Outperform | |
| 2010-11-16 | Reiterated | Rodman & Renshaw | Mkt Outperform | $6 to $7 |
| 2010-09-09 | Initiated | Jefferies | Buy | $7 |
| 2010-02-02 | Initiated | Rodman & Renshaw | Mkt Outperform | $6 |
| 2016-06-22 | Reiterated Rating | Craig Hallum | Buy | |
| 2016-06-22 | Reiterated Rating | Robert W. Baird | Outperform | $12.00 to $15.00 |
| 2016-06-16 | Upgrade | Craig Hallum | Hold to Buy | $6.00 to $18.00 |
| 2016-06-15 | Reiterated Rating | Mizuho | Hold | $6.50 |
| 2016-06-15 | Reiterated Rating | BTIG Research | Buy | $9.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In EXAS 325 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 16.68M |
| WELLINGTON MANAGEMENT CO LLP | 11.23M |
| BlackRock Inc. | 10.44M |
| Sumitomo Mitsui Trust Holdings, Inc. | 6.52M |
| Nikko Asset Management Americas, Inc. | 6.03M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.81M |
| STATE STREET CORP | 5.33M |
| Capital World Investors | 4.99M |
| BAILLIE GIFFORD & CO | 4.81M |
| JPMORGAN CHASE & CO | 4.63M |
| AMERIPRISE FINANCIAL INC | 3.68M |
| BlackRock Fund Advisors | 3.18M |
| BlackRock Institutional Trust Company, N.A. | 3.01M |
| OPPENHEIMER FUNDS INC | 2.50M |
| Point72 Asset Management, L.P. | 2.46M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Conroy Kevin T President & CEO | 1.06% (882439) | EPZM / EXAS / TWTI / |
| ARORA MANEESH Sr. VP & CFO | 0.78% (645089) | EXAS / TWTI / |
| CRAWFORD SALLY | 0.26% (212341) | EPRS / EXAS / HOLX / PODD / UAM / |
| LIDGARD GRAHAM PETER SVP, Chief Scientific Officer | 0.24% (201112) | EXAS / |
| THOMPSON DAVID | 0.24% (196444) | EXAS / TWTI / |
| Sterling Lionel | 0.15% (127575) | EXAS / TWTI / |
| ZENNER PATRICK J | 0.15% (124994) | ARQL / EXAS / WST / |
| Napier Katherine S | 0.13% (105814) | EXAS / HRC / TWTI / |
| Connelly James P | 0.10% (80513) | EXAS / TWTI / |
| WILLSEY LANCE | 0.09% (78033) | EXAS / EXEL / |
| LEVANGIE DANIEL J | 0.09% (73597) | EXAS / LPDX / PODD / |
| COWARD D SCOTT SVP and General Counsel | 0.08% (67001) | EXAS / |
| Carey Thomas D. | 0.06% (52410) | EXAS / |
| Megan William J. SVP, Finance & PFO | 0.06% (46807) | EXAS / |
| Berger Barry M SVP, Chief Medical Officer | 0.05% (44246) | EXAS / |
| Doyle James Edward | 0.04% (35181) | EXAS / |
| Fallon John A. | 0.04% (32910) | AMAG / EXAS / PODD / |
| Stoltenberg Laura S Chief Commercial Officer | 0.03% (26805) | EXAS / |
| Elliott Jeffrey Thomas Chief Financial Officer | 0.03% (21012) | EXAS / |
| WYZGA MICHAEL S | 0.02% (18376) | AKBA / EXAS / IDIX / OMED / RDUS / |
UM